Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Boyd Peter E.
Chief People Officer at Aquestive Therapeutics. Filing since 21 Nov 2018.
CIK 0001739816
Company
Date
Role
Action
Shares
Amount
Of holding
AQST
Aquestive Therapeutics, Inc.
10 Mar 2026
Chief People Officer
Sold at will
29,814
$124.41K
8.1%
AQST
Aquestive Therapeutics, Inc.
15 Oct 2025
See Remarks
Sold on a plan
10,000
$70.00K
3.6%
AQST
Aquestive Therapeutics, Inc.
26 Sep 2025
See Remarks
Sold on a plan
10,000
$63.00K
3.5%
AQST
Aquestive Therapeutics, Inc.
5 Sep 2025
See Remarks
Sold on a plan
15,000
$79.50K
4.9%
AQST
Aquestive Therapeutics, Inc.
14 Jun 2022
SVP-Bus. Process & Info. Tech.
Bought
5,000
$4.05K
9.2%
AQST
Aquestive Therapeutics, Inc.
8 Jun 2022
SVP-Bus. Process & Info. Tech.
Bought
2,293
$2.20K
4.4%
AQST
Aquestive Therapeutics, Inc.
16 Mar 2020
SVP-Bus. Process & Info. Tech.
Bought
2,000
$3.00K
4.0%
AQST
Aquestive Therapeutics, Inc.
12 Aug 2019
SVP-Bus. Process & Info. Tech.
Bought
600
$2.29K
1.2%
AQST
Aquestive Therapeutics, Inc.
21 Nov 2018
SVP-Operations/Value Delivery
Bought
200
$2.00K
0.4%
9 decisions on file.
